Tarek Baati | Nanobiotechnology | Best Scholar Award

Posted on by ScienceFather

Dr. Tarek Baati | Nanobiotechnology | Best Scholar Award

Dr. Tarek Baati, Institut National de Recherche et d’Ananlyse Physicochimique, Tunisia

Dr. Tarek Baati is a seasoned toxicologist and Senior Lecturer based in Tunisia. With an HDR from the Institut Supérieur de biotechnologie de Monastir in 2022, his extensive educational background includes a PhD in Toxicology from the University Paris11 in 2009. Dr. Baati has diverse expertise, from analytical chromatography to animal surgery techniques acquired during his formations in France. Proficient in languages such as French, English, and Arabic, he excels in in vitro, ex-vivo, and in vivo testing, tumor model development, and nanoparticle safety studies. Dr. Baati actively contributes to research, supervising students, and serving as a reviewer for Q1 Journals. His passion extends beyond science, embracing football, chess, photography, and DIY projects. 🧪📚🔬

🎓 Education & Qualifications:

2022: HDR (Institut Supérieur de Biotechnologie de Monastir). 2013: Analytical Chromatography and Separation Techniques, IUT- Orsay (France). 2012: Animal Surgery Techniques (Marseille, France). 2011: Transmission Electron Microscopy Techniques (Orsay, France). 2009: PhD in Toxicology, Faculty of Pharmacy, University Paris11. 2005: Master in Biology and Health, Institut Supérieur de Biotechnologie de Monastir.

🖥️ Informatics:

Proficient in Pack Office 2010, social networks, HPLC software (Empower, Chromquest), Image processing: ImageJ, Corel 12, Statistics (SPSS11)

🔬 Technical Skills:

Conducts in vitro, ex-vivo, and in vivo tests. Cell line culture and IC50 analysis. Migration tests in transwell chambers and immuno-fluorescence. Development of tumor models in nude mice. Study of nanoparticles safety and biodistribution. Application of nanoparticles for drug delivery and detoxification. Analysis of histopathological examination of organs. Extraction, purification, and testing of natural substances. Development and validation of analytical methods by HPLC-PDA. Assessment of biochemical markers. Supervision of Ph.D. and Master degree students. Reviewer for several Q1 Journals. Organization and participation in scientific meetings. Teaching toxicology and biochemistry.

🏅 Various:

Member of the Tunisian Association of Toxicology, Faculty of Pharmacy of Monastir. Interests: Football, Chess, Photography, DIY.

Professional Profiles:

The impact of her research is evident in citation metrics and indices from Google Scholar:

  • Cited by: All – 10271.
  • Citations – 10271.
  • h-index – 20.
  • Documents – 40.

A prolific researcher making meaningful contributions to the academic world!

🔬 Research Focus:

Dr. Tarek Baati’s research primarily focuses on the development and application of porous metal–organic-framework (MOF) nanoscale carriers for drug delivery and imaging, as evidenced by his extensive citations in the field. His work spans various aspects, including the use of MOFs in biomedicine, in-depth analysis of the in vivo toxicity of porous iron (III) MOFs, and the design of biodegradable therapeutic MOFs for delivering bioactive molecules. Additionally, he explores innovative approaches such as enhancing anti-HIV activity through MOF nanoparticles. Dr. Baati’s contributions also extend to studying the effects of nanomaterials on lifespan and investigating preventive measures against chromosome aberrations induced by certain compounds. 🧪🔬🌐

Publications Top Note:

Mónica L Fanarraga | Nanobiotechnology | Excellence in Research

Posted on by ScienceFather

Prof Dr. Mónica L Fanarraga | Nanobiotechnology | Excellence in Research

Prof Dr. Mónica L Fanarraga, Universidad de Catabria, Spain

👩‍🔬 Prof. Dr. Mónica L. Fanarraga🎓 An esteemed researcher and Professor at the University of Cantabria, Spain, Dr. Mónica L. Fanarraga is a trailblazer in nanomedicine. With dual PhDs in Biology and Medicine/Surgery, she founded the “Nanomedicine” research group at IDIVAL Institute. Over 40 competitive projects and 70 JCR publications showcase her impact. Recognized with the “Best Researcher Award” in 2022, she mentors researchers and champions innovation. Dr. Fanarraga’s recent projects secured substantial funding, affirming her dedication to cutting-edge nanomedicine research. Her contributions extend to patents, including groundbreaking work on silica nanoparticles, emphasizing her commitment to advancing scientific knowledge for over 30 years. 🌐🔬🏆

🏫 Education & Experience:

🎓 Degrees in Veterinary Medicine (1989). 📚 Dual PhDs in Biology (1993) and Medicine and Surgery (1999). 🧪 Founder of the “Nanomedicine” research group at IDIVAL Institute, Santander, Spain. 👩‍🏫 Current Professor at the University of Cantabria. 🏆 “Best Researcher Award” from Fenin (Spanish Platform for Innovation in Health Technology, 2022).

🔬 Academic Achievements:

🌐 Spearheaded over 40 competitive research projects in nanobiotechnology. 📚 Published 70+ JCR publications in esteemed journals. 📝 Principal Investigator for articles in journals like Adv. Healthc. Mat., J.Nanobiotech, Angewandte Chem, Nature, ACS Nano. 🏅 Secured 5 patents in the field of nanomedicine. 🎓 Mentored 10 postdoctoral researchers and supervised 14 defended doctoral theses. 🏅 6 theses received the “Extraordinary Prize,” 2 awarded the “Juan Mª Parés” Prize.

💡 Contributions to Research & Development:

🌟 Led successful projects, including TED2021-129248B-I00, securing €426,650 in funding. 💰 Secured funding for various Innovation projects, ranging from €15,000 to €56,100. 🌍 Actively involved in mentoring young scientists for national and international postdoctoral initiatives. 🏆 Key role in Marie Curie H2020-MSCA-IF-2019 project (€62,220) and Horizon-MSCA-Doctoral Networks 2021 project (€250,000).

🧪 Innovations in Nanomedicine:

🧬 Pioneering work on silica nanoparticles for nucleic acid encapsulation (2021). 🔄 Innovative approaches in protein (2017) and carbon nanotube conjugation of nanomaterials (2017). 🧠 Contributions to neurodegenerative disease research and advancements in gene transfer methods showcase continuous efforts in pushing scientific boundaries over 30 years.

Professional Profiles:

The impact of her research is evident in citation metrics and indices from Google Scholar:

  • Cited by: All – 2906.
  • Citations – 2906.
  • h-index – 29.
  • Documents – 100.

A prolific researcher making meaningful contributions to the academic world!

🔬 Research Focus:

🔍 Prof Dr. Fanarraga has made significant contributions in the fields of cell biology and nanomedicine. Her pioneering work encompasses critical areas such as organelle transport, microtubule dynamics, and controlled drug delivery systems. With a remarkable citation record, her impactful studies on dynactin’s role in bidirectional organelle transport (399 citations) and the uncoupling of hypomyelination and glial cell death (238 citations) showcase her expertise in cell biology. Additionally, her exploration of postchaperonin tubulin folding cofactors (163 citations) and their role in microtubule dynamics demonstrates a multifaceted approach to understanding cellular processes. Dr. Fanarraga’s diversified research extends to innovative applications, including magnetic hyperthermia-enhanced cell toxicity (125 citations) and the use of carbon nanotubes in mimicking microtubule properties (81 citations). Her extensive body of work reflects a commitment to advancing knowledge at the intersection of cellular biology and nanomedicine. 🌐🔬

Publications Top Note: